Expression of prokaryotic HhaI DNA methyltransferase is transforming and lethal to NIH 3T3 cells

Cancer Research

Volumn 56, Issue 3, 1996, Pages 616-622

  Wu, Jianjun ^a,b   Herman, James G ^a   Wilson, Geoffrey ^c   Lee, Ree Y ^a   Yen, Ray Whay Chiu ^a   Mabry, Mack ^a   De Bustros, Andrée ^a   Nelkin, Barry D ^e   Baylin, Stephen B ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW ENGLAND BIOLABS   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA METHYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; FIBROBLAST CULTURE; GENE EXPRESSION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROKARYOTE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL DEATH; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYTOSINE; DNA; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; METHYLATION; MICE; MOLECULAR SEQUENCE DATA; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); TRANSFECTION;

EID: 0030023142     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. El-Detry, W. S., Nelkin, B. D., Celano, P , Yen, R-W. C., Falco, J P., Hamilton, S. R., and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA, 88: 3470-3474, 1991.
2. Issa, J.-P., J., Vertino, P. M., Wu, J., Sazawal, S., Celano, P., Nelkin, B. D., Hamilton, S. R., and Baylin, S B. Increased cytosine DNA-methylatransferase activity during colon tumor progression. J. Natl. Cancer Inst., 85: 1235-1240, 1993.
3. Baylin, S B , Makos, M., Wu, J., Yen, R-W. C., de Bustros, A , Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383-390, 1991.
4. Laird, P. W., and Jaenisch, R. DNA methylation and cancer. Hum Mol. Genet., 3: 1487-1495, 1994.
5. Wu, J., Issa, J-P., Herman, J., Bassett, D E Jr., Nelkin, B. D., and Baylin, S. B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 90: 8891-8895, 1993.
6. Laird, P. W., Jackson-Grusby, L., Fazeli, A , Dickinson, S L., Jung, W. E., Li, E., Weinberg, R. A., and Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell, 81: 197-205, 1995
7. Cedar, H. DNA methylation and gene activity. Cell, 53: 3-4, 1988.
8. Tazi, J., and Bird, A. Alternative chromatin structure at CpG islands. Cell. 60: 909-920, 1990.
9. Boyes, J., and Bird, A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein Cell, 64: 1123-1134, 1991.
10. Keshet, I., Lieman-Hurwitz, J., and Cedar, H. DNA methylation affects the formation of active chromatin. Cell, 44: 535-543, 1986.
11. de Bustros, A , Nelkin, B D., Silverman, A , Ehrlich, G., Poiesz, B., and Baylin, S. B. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc. Natl. Acad. Sci. USA, 85. 5693-5697, 1988.
12. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
13. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48: 880-888, 1991.
14. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., and Sakai, T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8: 1063-1067, 1993.
15. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S R. Gnarra, J. R., Linehan W. M , and Baylin, S. B. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-977, 1994.
16. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Burger, P. C. Baylin, S. B., and Sidransky, D. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692, 1995.
17. Shen, J-C., Rideout, W M , III, and Jones, P. A. High frequency mutagenesis by a DNA methyltransferase. Cell, 71: 1073-1080, 1992.
18. Bestor, T. Activation of mammalian DNA methyltransferase by cleavage of a zinc-binding regulatory domain. EMBO J., 11: 2611-2617, 1992.
19. Bestor, T , Laudano, A., Mattaliano, R., and Ingram, V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol Biol., 203: 971-983, 1988.
20. Posfai, J., Bhagwat, A S , Posfai, G., and Roberts, R. J. Predictive motifs derived from cytosine methyltransferases. Nucleic Acids Res., 17: 2421-2435, 1989.
21. Yen, C. R-W., Vertino, P. M., Nelkin, B. D., Yu, J J., El-Deiry, W., Cumaraswamy, A , Lennon, G. G., Trask, B J , Celano, P., and Baylin, S B. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res., 20: 2287-2291, 1992.
22. Caserta, M., Zacharias, W , Nwankwo, D., Wilson, G. G., and Wells, R. D. Cloning, sequencing, in vivo promoter mapping, and expression in Escherichia coli of the gene for the HhaI methyltransferase. J. Biol. Chem., 262: 4770-4777, 1987
23. Cepko, C. L., Roberts, B., and Mulligan, R. C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell, 37: 1053-1062, 1984.
24. Morgenstern, J. P., and Land, H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res., 18: 1068, 1990.
25. Baker, S J., Markowitz, S , Fearon, E. R., Wilson, J. K. V , and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
26. Karasuyama, H , Tohyama, N., and Tada, T. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene J Exp. Med., 169: 13-25, 1989.
27. Peterson, M. G., and Mercer, J F Differential expression of four linked sheep metallothionein genes Eur J. Biochem., 174: 425-429, 1988.
28. Bonham, L , Kwok, J., Chisholm, O , and Symonds, G. Inducible transformation of fibroblasts using a metallothionein-v-myc gene construct. Oncogene, 6: 1073-1077, 1991.
29. Higachi, R Using PCR to engineer DNA. In: H. A. Erlich (ed.), PCR Technology, pp. 61-70. New York: Stockton Press, 1994.
30. Wyszynski, M W., Gabbara, S., Kubareva, E. A., Romanova, E. A., Oretskaya, T. S., Gromova, E. S., Shabarova, Z. A., and Bhagwat, A. S. The cysteine conserved among DNA cytosine methylases is required for methyl transfer, but not for specific DNA binding. Nucleic Acids Res., 21: 295-301, 1993
31. Wyszynski, M. W., Gabbara, S., and Bhagwat, A. S. Substitutions of a cysteine conserved among DNA cytosine methylases result in a variety of phenotypes Nucleic Acids Res., 20. 319-326, 1992
32. Graham, F. L., and van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
33. Corsaro, C. M., and Pearson, M. L. Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells. Somat. Cell Genet., 7: 603-616, 1981.
34. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G M., and Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA, 84: 7413-7417, 1987.
35. Bestor, T. H , and Ingram, V. H Two DNA methyltransferases from murine erythroleukemia cells, purification, sequence specificty, and mode of interaction with DNA. Proc. Natl. Acad. Sci. USA, 80: 5559-5563, 1983.
36. Bryans, M., Kass, S., Servwright, C., and Adams, R. L. Vector methylation inhibits transcription from the SV40 early promoter. FEBS Lett., 309: 97-102, 1992.
37. Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus Cell, 41: 521-530, 1985.
38. Keller, G., Paige, C., Gilboa, E., and Wagner, E. F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (Lond.), 318: 149-154, 1985
39. Mann, R., Mulligan, R. C., and Baltimore, D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33: 153-159, 1983.
40. Miller, A. D., Law, M-F., and Verma, I. M. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol., 5: 431-437, 1985.
41. Renbaum, P. and Razin, A. Mode of action of the spiroplasma CpG methylase M.SssI. FEBS Lett., 313: 243-247, 1992.
42. Renbaum, P., Abrahamove, D , Fainsod, A., Wilson, G. G., Rottem, S., and Razin, A Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1(M.SssI). Nucleic Acids Res., 18: 1145-1152, 1990.
43. Kwoh, T. J , Kwoh, D. Y., McCue, A. W., Davis, G. R., Patrick, D., and Gingeras, T. R. Introduction and expression of the bacterial PaeR7 methylase gene in mammalian cells. Proc. Natl. Acad. Sci. USA, 83: 7713-7717, 1986.
44. Baylin, S. B., Fearon, E R., Vogelstein, B., de Bustros, A , Sharkis, S. J., Burke, P. J., Staal, S. P., and Nelkin, B. D. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood, 70: 412-417, 1987.
45. Jones, P. A., and Buckley, J. D. The role of DNA methylation in cancer. Adv. Cancer Res., 54: 1-23, 1990.
46. Jones, P. A., Wolkowicz, M. J., Rideout, W. M., III, Gonzales, F. A., Marziasz, C. M., Coetzee, G. A , and Tapscott, S. J De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. USA, 87: 6117-6121, 1990.
47. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B , and Baylin, S. B Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer Proc. Natl. Acad. Sci USA, 89: 1929-1933, 1992.
48. Makos, M., Nelkin, B. D , Reiter, R. E., Gnarra, J. R., Brooks, J , Isaacs, W., Linehan, M , and Baylin, S B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53. 2719-2722, 1993.
49. Makos, M , Nelkin, B. D., Chazin, V R , Cavenee, W. K., Brodeur, G. M., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53. 2715-2718, 1993.
50. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
51. Rideout, III, W. M., Coetzee, G. A , Olumi, A F., and Jones, P. A. 5-Methylcytosine as an endogenous mutagen in human LDL receptor and p53 genes. Science (Washington DC), 249: 1288-1290, 1990.
52. Cooper, D. N., and Youssoufian, H. The CpG dinucletide and human genetic diseases. Hum. Genet., 78: 151-155, 1988.
53. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers (Review). Science (Washington DC), 253: 49-53, 1991.
54. Wu, J. C , and Santi, D. V Kinetic and catalytic mechanism of HhaI methyltransferase J Biol Chem., 262. 4778-4786, 1987.
55. Osterman, D G , DePillis, G. D., Wu, J. C., Matsuda, A , and Santi, D. V. 5-Fluorocytosine in DNA is a mechanism-based inhibitor of HhaI methylase. Biochemistry, 27: 5204-5210, 1988.
56. Nowell, P C The clonal evolution of tumor cell populations. Science (Washington DC), 194 23-28, 1976.